Clinical Trials Directory

Trials / Completed

CompletedNCT06983379

Oxidative Stress and Vitamin D Levels in Autism Spectrum Disorders

Oxidative Stress and Vitamin D Levels in Autism Spectrum Disorders: An Original Clinical Investigation

Status
Completed
Phase
Study type
Observational
Enrollment
68 (actual)
Sponsor
Mardin Artuklu University · Academic / Other
Sex
All
Age
0 Years – 18 Years
Healthy volunteers
Accepted

Summary

Oxidative Stress and Vitamin D Levels in Autism Spectrum Disorders

Detailed description

Introduction: The etiology of Autism Spectrum Disorder (ASD) is thought to be complex. Increasing evidence in the literature shows that oxidative stress plays a role in the development and prognosis of autism. In our study, investigators aimed to investigate whether thiol disulfide balance, which is a new marker of oxidative stress, is different from that in normal children with autism spectrum disorder. Methods A total of 68 children, 38 with autism spectrum disorder and 30 healthy controls, were included in the study. Dynamic thiol balance, total oxidant status, total antioxidant status, ischemia-modified albumin, paraoxonase 1, and arylesterase activities were measured using colorimetric methods. Routine biochemical parameters were obtained from their files and evaluated.

Conditions

Timeline

Start date
2020-01-03
Primary completion
2021-06-30
Completion
2023-01-30
First posted
2025-05-21
Last updated
2025-05-21

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06983379. Inclusion in this directory is not an endorsement.